HOW THE J&J CASE UNFOLDED
The US
2010: DePuy, a manufacturer for J&J recalls, 93,000 ASR hip-replacement systems
2013: DePuy stops selling ASR hip-replacement systems after the US FDA tightens rules
J&J says it has paid $2.5-billion ASR settlement to around 8,000 patients in the US
2013-2019: Nearly 10,400 lawsuits filed in the US over the failure of device
2019: J&J pays $120 million to resolve deceptive marketing claims made in the US
India
2010: The CDSCO gives DePuy’s fresh imports licence for implants on the basis of renewed registration 2011: The CDSCO asks J&J for details of compensation paid to victims; the company says the information is confidential
2012: The CDSCO cancels import of J&J ASR hip-replacement system
2013: DePuy stops selling ASR hip-replacement systems after the US FDA tightens rules
2014: CDSCO receives patient grievances on ASR implants, takes it up with company
2017: An expert committee of the health ministry formed to look into the issue
2018: The expert committee makes report public, suggests ~33 lakh as minimum penalty
2019: The government accepts the committee report, says the firm must pay within 30 days The CDSCO asks J&J to pay a penalty of nearly
~75 lakh to a Mumbai-based victim